Scarica l'app Stockscreener
5.42
0.18%
0.010
Dopo l'orario di chiusura:
5.43
0.010
+0.18%
Precedente Chiudi:
$5.41
Aprire:
$5.41
Volume 24 ore:
770.44K
Relative Volume:
0.64
Capitalizzazione di mercato:
$1.22B
Reddito:
$596.48M
Utile/perdita netta:
$123.72M
Rapporto P/E:
9.8833
EPS:
0.5484
Flusso di cassa netto:
$106.59M
1 W Prestazione:
-0.73%
1M Prestazione:
+0.74%
6M Prestazione:
+41.88%
1 anno Prestazione:
+50.14%
Intervallo 1D:
$5.40
$5.44
Intervallo di 1 settimana:
$5.38
$5.47
Portata 52W:
$2.37
$5.72
Curevac N V Stock (CVAC) Company Profile
Confronta CVAC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVAC
Curevac N V
|
5.42 | 1.22B | 596.48M | 123.72M | 106.59M | 0.5484 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.16 | 120.29B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
554.58 | 60.26B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
339.80 | 43.10B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
598.89 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.94 | 33.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Curevac N V Stock (CVAC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-13 | Downgrade | Jefferies | Buy → Hold |
| 2024-04-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2023-06-08 | Iniziato | SVB Securities | Outperform |
| 2023-01-19 | Aggiornamento | UBS | Neutral → Buy |
| 2023-01-09 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-01-21 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-01-18 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-10-22 | Iniziato | Deutsche Bank | Hold |
| 2021-06-17 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-04-26 | Ripresa | Credit Suisse | Underperform |
| 2021-04-26 | Iniziato | Guggenheim | Neutral |
| 2020-12-10 | Downgrade | Credit Suisse | Neutral → Underperform |
| 2020-09-08 | Iniziato | BofA Securities | Buy |
| 2020-09-08 | Iniziato | Credit Suisse | Neutral |
| 2020-09-08 | Iniziato | Jefferies | Hold |
Mostra tutto
Curevac N V Borsa (CVAC) Ultime notizie
Short Covering May Lift CureVac N.V. in Near TermRisk Adjusted Technical Entry Plan Gains Followers - metal.it
CureVac N.V.Finanzen.net - Finanzen.net
Will CureVac N.V. stock benefit from AI tech trendsWatchlist for Smart Swing Trading Updated - metal.it
How volatile is CureVac N.V. stock compared to the marketIdentify winners with top-tier analysis - jammulinksnews.com
Traders Consider Averaging Down in CureVac N.V.Smart Investment Tips Gaining Popularity Among Analysts - metal.it
What are analysts’ price targets for CureVac N.V. in the next 12 monthsInvest confidently with professional market insights - jammulinksnews.com
How does CureVac N.V. generate profit in a changing economyTremendous wealth creation - jammulinksnews.com
Why is CureVac N.V. stock attracting strong analyst attentionMaximize returns with expert trading insights - jammulinksnews.com
When is CureVac N.V. stock expected to show significant growthExceptional portfolio growth - jammulinksnews.com
What is the dividend policy of CureVac N.V. stockBuild a balanced portfolio for long-term success - jammulinksnews.com
Should I hold or sell CureVac N.V. stock in 2025Maximize profits with strategic stock selection - jammulinksnews.com
What drives CureVac N.V. stock priceExplosive trading opportunities - PrintWeekIndia
Will CureVac N.V. stock benefit from interest rate changesFree Stock Market Real-Time Monitoring - jammulinksnews.com
Is CureVac N.V. a good long term investmentMarket-beating returns - Autocar Professional
What analysts say about CureVac N.V. stockExponential return rates - Autocar Professional
CureVac N.V. Stock Analysis and ForecastUnmatched profit potential - jammulinksnews.com
CureVac Soars 41% in a Month on a $1.25B Buyout Offer From BioNTech - MSN
CureVac: Pipeline pruning’s nasty effect - MarketScreener
CureVac N.V. (CVAC) Has Gained Over 16% In One Month. Here Is Why - Insider Monkey
Tesla chief Elon Musk teams up with Covid-19 player CureVac to build ‘RNA microfactories’ - Endpoints News
CureVac Announces Key Resolutions from Annual Shareholders Meeting - TipRanks
Curevac N V Azioni (CVAC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.23%
0.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):